Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF) announces that its proprietary cannabinoid medicine Zenivol™ can now be prescribed to patients in Australia through the Therapeutic Goods Administration’s (TGA) Special Access Scheme and via Authorized Prescribers. Zenivol™ is available for immediate […]